Fresko I, Yazici H, Bayramiçli M, Yurdakul S, Mat C. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçet's syndrome. Ann Rheum Dis 1993; 52:619-620.
Fresko I, Yazici H, Isçi H. Genital ulceration in patients with systemic lupus erythematosus. Lupus 1993; 2(2): 135.
Roux H, Fresko I. Behçet's disease: a disease in search of its etiology. Rev Rhum Engl Ed 1995; 62(5): 339-342.
Fresko I, Soy M, Hamuryudan V, Yurdakul S, Yavuz S, Tümer Z and Yazici H. Genetic anticipation in Behçet's syndrome. Ann Rheum Dis. 1998; 57: 45-48.
Yavuz S, Fresko I, Hamuryudan V, Yurdakul S and Yazici H. Fibromyalgia in Behçet's syndrome. J Rheumatol 1998; 25: 11: 2219-2220.
Istanbul Rheumatology Study Group and .Saruhan Direskeneli.G ( Fresko I, Hamuryudan V, Hizli N, Özdogan H, Yazici H, Yurdakul S, Aral O, Gül A, Inanç M, Koniçe M, Öcal L, Akoglu T, Direskeneli H). Shared Epitope “Homozygosity” is strongly associated with Rheumatoid Arthritis in Turkey . British Journal Of Rheumatology 1998; 37: 1126-1128.
Korkmaz C, Fresko I, Yazici H. A case of systemic sclerosis that developed under dexfenfluramine use. Rheumatology 1999; 38 (4): 379-380.
Saylan T, Mat C, Fresko I, Melikoglu M. Behçet's Disease in the Middle East . Clinics in Dermatology; 1999; 17(2): 209-222.
Ertan S, Fresko I, Apaydin H, Özekmekçi S and Yazici H. Extrapyramidal type rigidity in Rheumatoid Arthritis. Rheumatology 1999; 38: 627-630.
Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, Yazici H. Evaluation of the Turkish translation of a disease activity form for Behçet's Syndrome. Rheumatology. Rheumatology 1999; 38: 734-736.
Fresko I, Yurdakul S, Hamuryudan V, Özyazgan Y, Mat C, M. Tanverdi M, Yazici H. The management of Behçet's Syndrome. Annales de Medicine Interne 1999; 150(7): 576-581.
Eksioglu-Demiralp E, Direskeneli H, Ergun T, Fresko I, Akoglu T. Increased CD14 + CD16 + and CD4 + CD56 + T cell subsets in Behçet's disease. Rheumatol Int 1999; 19(1-2): 23-26.
Melikoglu M, Özdogan H, Korkmaz C, Kasapçopur O, Arisoy N, Akkus S, Fresko I, Yazici H. A survey of Phenotype II in Familial Mediterranean Fever. Ann Rheum Dis 2000; 59(11): 910-3.
Siva A, Fresko I. Behçet's disease. Current treatment options in Neurology; 2000; 2(5): 435-448.
Fresko I, Hamuryudan V, Demir M, Hizli N, Sayman H, Melikoglu M, Tunç R, Yurdakul S, Yazici H. Intestinal permeability in Behçet's Syndrome. Ann Rheum Dis 2001: 60(1): 65-6.
Melikoglu M, Altiparmak R, Fresko I, Tunç R, Yurdakul S, Hamuryudan V, Yazici H. A reappraisal of amyloidosis in Behçet's syndrome. Rheumatology 2001; 40: 212-215.
Kotter I, Gunaydin I, Stubiger N, Yazici H, Fresko I, Zouboulis CC, Adler Y, Steiert I, Kurz B, Wernet D, Braun B, Muller CA. Comparative analysis of the association of HLA-B*51 suballeles with Behcet's disease in patients of German and Turkish origin. Tissue Antigens. 2001 Sep;58(3):166-70.
Dinc A, Melikoglu M, Korkmaz C, Fresko I, Ozdogan H, Yazici H. Nailfold capillary abnormalities in patients with familial Mediterranean fever. Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S42-4.
Fresko I. Highlights of the 10th International Congress on Behcet's Disease.
Clin Exp Rheumatol. 2002 Jul-Aug;20(4 Suppl 26):S59-64.
Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H. Target organ associations in Turkish patients with Behcet's disease: a cross sectional study by exploratory factor analysis. J Rheumatol. 2002 Nov;29(11):2393-6.
Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center.
Medicine ( Baltimore ). 2003 Jan;82(1):60-76.
Altiparmak MR, Pamuk ON, Fresko I. Massive hematuria in rheumatoid arthritis: an unusual manifestation of reactive amyloidosis. Clin Exp Rheumatol. 2003 Nov-Dec;21(6):799-800.
Mumcu G, Ergun T, Inanc N, Fresko I, Atalay T, Hayran O, Direskeneli H. Oral health is impaired in Behcet's disease and is associated with disease severity. Rheumatology ( Oxford ). 2004 Aug;43(8):1028-33.
Caliskan R, Masatlioglu S, Aslan M, Altun S, Saribas S, Ergin S, Uckan E, Koksal V, Oz V, Altas K, Fresko I, Kocazeybek B. The relationship between arthritis and human parvovirus B19 infection.
Rheumatol Int. 2005 Nov;26(1):7-11.
Hamuryudan V, Er T, Seyahi E, Akman C, Tuzun H, Fresko I, Yurdakul S, Numan F, Yazici H. Pulmonary artery aneurysms in Behcet syndrome. Am J Med. 2004 Dec 1;117(11):867-70.
Fresko I, Seyahi E, Yurdakul S. Infliximab and primary Sjogren's syndrome: comment on the article by Mariette et al. Arthritis Rheum. 2004 Dec;50(12):4077
Melikoglu M, Fresko I, Mat C, Ozyazgan Y, Gogus F, Yurdakul S, Hamuryudan V, Yazici H. Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study. J Rheumatol. 2005 Jan;32(1):98-105.
Inanc N, Mumcu G, Birtas E, Elbir Y, Yavuz S, Ergun T, Fresko I, Direskeneli H. Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity. J Rheumatol. 2005 Feb;32(2):287-91.
Direskeneli H, Fresko I, Hamuryudan V. Effects of interferon-alpha treatment on serum IL-6, IL-8, TNF-alpha and soluble TNF-alpha receptors in Behcet's disease. Scand J Rheumatol. 2005;34(1):75-6.
Mat C, Yurdakul S, Uysal S, Gogus F, Ozyazgan Y, Uysal O, Fresko I, Yazici H. A double-blind trial of depot corticosteroids in Behcet's syndrome. Rheumatology (Oxford). 2006 Mar;45(3):348-52.
Yazici H, Fresko I. Behcet's disease and other autoinflammatory conditions: what's in a name?
Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S1-2.
Yurdakul S, Hekim N, Soysal T, Fresko I, Bavunoglu I, Ozbakir F, Tabak F, Melikoglu M, Hamuryudan V, Yazici H. Fibrinolytic activity and d-dimer levels in Behcet's syndrome.
Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S53-8.
Fresko I, Ugurlu S, Ozbakir F, Celik A, Yurdakul S, Hamuryudan V, Yazici H. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome. Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S67-70.
Gogus F, Fresko I, Elbir Y, Eksioglu-Demiralp E, Direskeneli H. Oxidative burst response to monosodium urate crystals in patients with Behcet's syndrome. Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S81-5.
Seyahi E, Seyahi N, Fresko I, Kuyumcu M, Yazici H. Hair diameter in systemic lupus erythematosus. Lupus. 2006;15(5):282-4.
Saruhan-Direskeneli G, Bicakcigil M, Yilmaz V, Kamali S, Aksu K, Fresko I, Akkoc N, Kiraz S, Ozer HT, Tunc E, Yucel E, Karaarslan Y, Uyar FA, Doganavsargil E, Inanc M, Direskeneli H; Rheumatology Education and Research Society Vasculitis Study Group. Interleukin (IL)-12, IL-2, and IL-6 gene polymorphisms in Takayasu's arteritis from Turkey. Hum Immunol. 2006 Sep;67(9):735-40.
Seyahi E, Fresko I, Melikoglu M, Yazici H. The management of Behcet's syndrome.
Acta Reumatol Port. 2006 Apr-Jun;31(2):125-31. Review.
Hatemi G, Melikoglu M, Fresko I, Masatlioglu S, Tascilar K, Yazici H. Infliximab does not suppress the tuberculin skin test (purified protein derivative). J Rheumatol. 2007 Mar;34(3):474-80.
Yazici H, Fresko I, Yurdakul S. Behcet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol. 2007 Mar;3(3):148-55.
Seyahi E, Hamuryudan V, Hatemi G, Melikoglu M, Celik S, Fresko I, Yurdakul S, Yazici H. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome. Rheumatology (Oxford). 2007 Jul;46(7):1213-4.